JATT II Acquisition Corp.
corporate_fare Company Profile
JATT II Acquisition Corp. (NASDAQ:JATT) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 10 items for JATT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-25, rated 7/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for JATT spans 10-Q, 425, 8-K.
Recent high-impact activity:
- JATT III Acquisition Corp Prices $60M IPO at $10 Per Share
- JATT II 10-Q Discloses $225M PIPE Financing Terms for Talawar Merger
- JATT II Acquisition Corp. Finalizes Merger with Talawar Therapeutics, Securing $285M for Biotech Pipeline
- JATT II Announces Definitive Merger with Talawar Therapeutics, Secures $225M Oversubscribed PIPE
- JATT II Acquisition Corp. Announces Definitive Business Combination with Talawar Tx Inc. and $225M PIPE
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 6,134 shares in JATT as of the September 15, 2026 settlement, a 41.7% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 30.6% of JATT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.